𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Implications for the Use of Topoisomerase I Inhibitors in Treatment of Patients with Systemic Sclerosis

✍ Scribed by LIDIA RUDNICKA; JOANNA CZUWARA; AGNIESZKA BARUSIŃSKA; URSZULA NOWICKA; BARBARA MAKIELA; STEFANIA JABLONSKA

Book ID
119872965
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
167 KB
Volume
803
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of an immunodominant epitope of
Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosis
✍ T. M. Meesters; M. Hoet; F. H. J. Hoogen; R. Verheijen; W. J. Habets; W. J. Venr 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 737 KB

In this paper an immunodominant epitope of Topoisomerase I is described. An epitope expression sublibrary was constructed from Topoisomerase I cDNA. The subclones were screened with an antiserum from a patient with systemic sclerosis (SSc). The positive clones defined one immunodominant B cell epito

Direct binding of anti–DNA topoisomerase
Direct binding of anti–DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis
✍ Jill Hénault; Mélanie Tremblay; Isabelle Clément; Yves Raymond; Jean-Luc Senécal 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 2 views

## Abstract ## Objective Fibroblasts play a crucial role in the development of systemic sclerosis (SSc), and antifibroblast antibodies (AFAs) capable of inducing a proinflammatory phenotype in fibroblasts have been detected in the sera of SSc patients. This study examined the prevalence of AFAs in